Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04187729 · ClinicalTrials.gov registry record

Precision Genomics Medicine Biobank

A clinical trial of Any Disease Condition and Reportedly-healthy Subjects, sponsored by Intermountain Health Care.

Recruiting
Registry status
100,000
Enrollment target
1
Study location

NCT04187729 is a study of Any Disease Condition and Reportedly-healthy Subjects that is actively recruiting participants, run by Intermountain Health Care. The registered enrollment target is 100,000 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04187729, a study of Any Disease Condition and Reportedly-healthy Subjects, is actively recruiting participants, sponsored by Intermountain Health Care.

RECRUITING
Registry status
100,000 participants
Enrollment target
1
Study location

Study Summary

The immediate goal of this study is to collect biological samples (i.e., tissue and/or fluid), clinical information, and laboratory data from disease and non-disease subjects seen at Intermountain Healthcare affiliated facilities. The long-term goal is to annotate tissue and/or fluid biomarker data to clinical information and laboratory data for the purpose of improving health care delivery and prognostic potential.

Study Locations (1)

Utah

  • Intermountain Healthcare - Murray

Trial Details

FieldValue
Enrollment Target 100,000 participants
Start Date 2017-10-24
Est. Completion 2077-10-24

Sponsor

Intermountain Health Care

85 total trials

What the Registry Record Tells You About NCT04187729

The ClinicalTrials.gov registry entry for NCT04187729 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Intermountain Health Care, which has 85 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Any Disease Condition and Reportedly-healthy Subjects appearing as the primary indexed condition, and to 0 interventions.

NCT04187729 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT04187729 about?

NCT04187729 is a clinical study titled "Precision Genomics Medicine Biobank". The immediate goal of this study is to collect biological samples (i.e., tissue and/or fluid), clinical information, and laboratory data from disease and non-disease subjects seen at Intermountain Healthcare affiliated facilities. The long-term goal is to annotate tissue and/or fluid biomarker data ...

What is the current status of trial NCT04187729?

This trial is currently recruiting. The enrollment target is 100,000 participants. The study started on 2017-10-24. Estimated completion is 2077-10-24.

What conditions does trial NCT04187729 study?

This clinical trial studies the following conditions: Any Disease Condition and Reportedly-healthy Subjects.

Who is sponsoring clinical trial NCT04187729?

This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04187729 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.